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Abstract
Background: Tick-borne Babesia bigemina is responsible for acute and potentially lethal hemolytic disease in cattle.
The development of genetic manipulation tools necessary to the better understanding of parasite biology is currently
limited by the lack of a complete parasite genome and experimental tools such as transfection. Effective promoters,
required to regulate expression of transgenes, such as the elongation factor-1 alpha (ef-1α), have been identified in
other apicomplexans such as Babesia bovis and Plasmodium falciparum.
Methods: The B. bigemina ef-1a locus was defined by searching a partial genome library of B. bigemina (Sanger
Institute). Presence of an intron in the 5’ untranslated region was determined by 5’ Rapid Amplification of cDNA Ends
(RACE) analysis. Promoter activity was determined by measurement of luciferase expression at several time points after
electroporation, efficiency of transfections and normalization of data was determined by quantitative PCR and by the
percentage of parasitized erythrocytes.
Results: The ef-1α locus contains two identical head to head ef-1α genes separated by a 1.425 kb intergenic
(IG) region. Significant sequence divergence in the regions upstream of the inverted repeats on each side of
the B. bigemina IG region suggest independent regulation mechanisms for controlling expression of each of
the two ef-1α genes. Plasmid constructs containing the 5’ and 3’ halves of the IG regions controlling the
expression of the luciferase gene containing a 3’ region of a B. bigemina rap-1a gene, were generated for the
testing of luciferase activity in transiently transfected parasites. Both halves of the ef-1α IG region tested showed the
ability to promote high level production of luciferase. Moreover, both B. bigemina ef-1α promoters are also active in
transiently transfected B. bovis and conversely, a B. bovis ef-1α promoter is active in transiently transfected B. bigemina.
Conclusions: Collectively these data demonstrate the existence of two distinct promoters with homologous and
heterologous promoter function in B. bigemina and B. bovis which is described for the first time in Babesia
species. This study is of significance for development of interspecies stable transfection systems for B. bigemina
and for B. bovis.
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Background
Tick and tick-borne diseases (TBDs) have vast impact
on food production and public health. Bovine babesiosis
is recognized among the most important TBD in terms
of economic losses worldwide [1]. Bovine babesiosis can
be in part controlled using live attenuated vaccines, but
these vaccines are challenging to produce and distribute,
have safety risks and a limited shelf life [2]. The exist-
ence of numerous research gaps concerning host-
parasite relationships limit options for the development
of improved methods for control. Novel research tools
are needed in order to close such knowledge gaps and
support development of new methods to control Babesia
parasites and its vectors [3]. Babesia bovis and B. bige-
mina are the main parasites responsible for bovine
babesiosis in terms of global parasite distribution, while
Babesia divergens is mainly prevalent in the European
continent [1].
In general B. bovis is regarded as the most virulent
Babesia parasite, whereas, B. bigemina causes acute
hemolytic disease [4]. Although the B. bovis genome and
transfection systems were developed several years ago
[5, 6], the genome for B. bigemina remains incomplete
and unassembled (http://www.sanger.ac.uk/resources/
downloads/protozoa/babesia-bigemina.html), and gene
editing and transfection systems for B. bigemina remain
unavailable. Attenuated transfected Babesia parasites are
ideal candidates for delivery of anti-tick or other anti-
TBD agents’ vaccine antigens [7]. Considering that B.
bigemina has a wider range of tick vectors than B. bovis,
including Rhipicephalus (Boophilus) microplus [8], B.
annulatus [9] and B. decoloratus [10, 11] this parasite
should also be considered as an efficient candidate for the
development of dual parasite-vector vaccine approaches.
Gene editing and transfection systems, in addition to a
complete genome, are required in order to advance our
understanding of the molecular biology of B. bigemina
parasites and for improved vaccine development. A
current limitation for the development of such gene ana-
lysis systems is the lack of defined B. bigemina pro-
moters and a method to introduce foreign DNA into B.
bigemina. The promoters controlling the expression of
elongation factor 1-alpha (ef-1α) genes in apicomplexan
parasites are generally regarded as strong constitutive
promoters [12, 13]. In B. bovis the ef-1α includes an ar-
rangement of two identical head to head genes separated
by a 1.4 kb region containing two apparently distinct pro-
moters [12, 13]. Therefore a rational approach for the
identification of B. bigemina promoters consists of search-
ing for the presence of a similar structural and functional
arrangement for the ef-1α locus in this parasite.
Given the current unavailability of a genetic system to
better characterize the molecular basis for B. bigemina
virulence and to facilitate vaccine development, we
posed to define promoters and a method to introduce
foreign DNA into the parasite. In this study we describe
the ef-1α locus of B. bigemina, and tested the activity of
ef-1α promoters. The data generated in this study may
serve as the foundation for the future development of
urgently needed gene editing and stable transfection
systems for B. bigemina.
Methods
Parasites
The B. bigemina Puerto Rico strain [14] and B. bovis
Texas S74T3Bo strain [15] were grown in long-term
microaerophilous stationary-phase (MASP) culture using
previously described methods [16, 17]. Parasites were
obtained from 4 12.5 cm3-flask expansions of B. bige-
mina cultures containing approximately 25 % infected
red blood cells (iRBC) as determined by microscopic
counting of Diff-Quick-stained (Dade Behring, Deerfield,
USA) slides. Infected red blood cells from the expansion
were centrifuged for 10 min at 400× g. The cell pellet
was suspended in 4 ml of Cytomix (120 mM KCl,
0.15 mM CaCl2, 10 mM K2HPO4/KH2PO4, 25 mM
HEPES, 2 mM EGTA, 5 mM MgCl2, pH 7.6) and centri-
fuged again for 10 min at 400× g. The supernatant was
removed and the tube of packed red blood cells was
placed on ice until needed (Electroporation sub-section).
Parasite DNA extraction
Genomic DNA (gDNA) was extracted from cultured B.
bigemina Puerto Rico strain and cultured B. bovis Texas
strain using the Qiagen Blood core kit (Valencia, USA)
following the manufacturer’s instructions. The same kit
was used to extract plasmid DNA (pDNA).
Identification and sequencing of the Babesia bigemina
ef-1α locus of the Puerto Rico strain
BLAST searches of the unfinished B. bigemina genome at
the Sanger website (http://www.sanger.ac.uk/resources/
downloads/protozoa/babesia-bigemina.html) were per-
formed using the B. bovis ef-1α orf as a query (GenBank
accession number: ALH43162.1). The full sequence of
the ef-1α gene A in the B. bigemina Puerto Rico strain
was determined by PCR analysis using the ef-1α orf re-
verse primer (Ef1α-Rev): 5′-CTT CTT GGA GGC CTT
CTG GGC TG-3′ in conjunction with a primer present
in the IG region, Ig-A-forward (Ig-A-Fwd): 5′-ATT
AGG AAG CTT TAC AGA GGA CAT ACT TTA CTT
G-3′ containing a HindIII restriction site at 5′ end.
Primers Ig-A-Fwd and Ef1α-Rev and Ig-B-forward (Ig-
B-Fwd): 5′-ATT AGG AAG CTT CAA GTA AAG TAT
GTC CTC TG-3′ containing a HindIII restriction site
at 5′ end and Ef1α-Rev were used to amplify both
halves of the full ef-1α locus (Fig. 1). Both 2.075 and
2.063 kb amplicons were cloned into TOP-TA pCR2.1
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cloning vector (Life technologies, Carlsbad, USA) and
fully sequenced.
Transfection plasmid constructs
Babesia bigemina gDNA was amplified using primers to
amplify the Ig-A and Ig-B IG regions. For the Ig-A region
a set of primers Ig-A-Fwd and IG-FS-reverse: 5′-CTT
CTT GGA GGC CTT CTG GGC TG-3′, each containing
a HindIII restriction site at the 5′ end, were used to amp-
lify a 709 bp fragment. For the Ig-B region the set of
primers Ig-B-Fwd and IG-FS reverse (sequence described
above), each containing a HindIII restriction site at the 5′
end, were used to PCR amplify a 716 bp fragment. PCR
products from both promoters were cloned into the TOP-
TA pCR2.1 cloning vector (Life technologies) for sequence
confirmation. Both Ig-A and Ig-B regions were then
digested from the pCR2.1 plasmids with HindIII restric-
tion enzyme (Promega, Madison, USA) and ligated into
the linearized HindIII digested promoter-less “4-35-ef-luc”
plasmid which contained the luciferase gene in the EcoRI
site and the 3′ region of the B. bigemina rap-1 in the PstI
site. All plasmids were sequenced to confirm that the
promoters were in the correct orientation. A small 245 bp
region of the 3′ region of B. bigemina rap-1a gene was
amplified from gDNA of B. bigemina using the set of
primers 3′ rap-a forward: 5′-GCG TCT CTG CAG TAA
CAG CAA TTT AGC TGT AC-3′ and 3′ rap-a-reverse:
5′-CCG TAA CTG CAG ACA CGC TAT CTA CGG
CCA TGG TGG C-3′, each containing a PstI restriction
site at the 5′ end. The B. bovis 3′ rap-1 region of the “4-
35-ef-luc” plasmid was removed by digesting with PstI
restriction enzyme and replaced by ligation with the 245
base pair rap-1a 3′ region from the rap-1a gene of B. bige-
mina utilizing the same PstI restriction site.
RACE analysis: Analysis of B. bigemina ef-1α gene A
transcripts
The B. bigemina ef-1α cDNA was specifically amplified
using the SMARTer RACE cDNA Amplification Kit
(Clontech, Mountain View, USA) protocol, the Advan-
tage 2 PCR enzyme system and universal primer mix
(UPM): 5′-CTA ATA CGA CTC ACT ATA GGG CAA
GCA GTG GTA TCA ACG CAG AGT–3′. Primers
race-1-ef-1α: 5′-CGT TCT TGG AGT CAG AAG CGA
CGT GAC C-3′; race-2-ef-1α: 5′-GTA CGC TTG TCC
ATA CGG CTG GTG ATC-3′; and race-3-ef-1α: 5′-
CAG GGC TGG CAA CAT CGA TAA CTT CGT G-3′
were used for specific amplification of B. bigemina ef-1α
gene A transcripts and amplified 5′ RACE products
were cloned in vector 2.1-TOPO and sequenced.
Fig. 1 Definitive structure of the B. bigemina ef-1α locus. The structure of the B. bigemina ef-1α locus (upper panel) was deduced from the
amplification of the PCR products obtained after amplification (lower panel). The previously 767 bp unknown sequence of the ef-1α locus is
represented with a grey box. The location of primers used for the PCR amplification is marked with arrows. The regions on the IG containing
IR repeats are represented by blue boxes, and the location of a ClaI site present in the IG region is also indicated with an arrow. PCR analysis
performed on total B. bigemina gDNA amplicons on an agarose gel electrophoresis (lower panel). Lane 1, PCR product for Ig-A-Fwd + IG-FS-
Rev primer; Lane 2, PCR product for Ig-B-Fwd + IG-FS-Rev. Molecular size marker is indicated on the left. Abbreviation: M, molecular size ladder
in base pair (bp), 1000 bp DNA ladder
Silva et al. Parasites & Vectors  (2016) 9:576 Page 3 of 9
Electroporation
All electroporations were performed in a Gene Pulser II
apparatus (BioRad, Richmod, USA) using 0.2-cm cu-
vettes. Twenty μg of plasmid was dried down in a Speed-
vac (Savant, Pittsburgh, USA) and suspended in 25 μl of
Cytomix. Then, 37.5 μl of packed RBC were suspended
in an equal volume of Cytomix, mixed with the plasmid
briefly and transferred to a 0.2 cm cuvette follow elec-
troporation. The conditions for electroporation were:
1.2 kV, 200 Ω and 25 μF. After electroporation, the cells
were transferred to the well of a 48-well plate containing
5 % normal RBCs and HL-1 media with 40 % bovine
serum to a final volume of 465 μl. The plate was then
placed in the incubator until the luciferase assay was
carried out. After electroporation, merozoites were
cultured in vitro as described above.
Luciferase assays
Luciferase analysis was performed as previously de-
scribed in Suarez et al. [18]. Briefly, luciferase assays
were performed using Promega’s LAR II detection re-
agent at room temperature and a Turner Designs TD-
20/20 Tube Luminometer for a 10 s integration interval.
For each set of luciferase assays, 2 μl of a 10-6 dilution of
Promega’s QuantiLum Recombinant Luciferase diluted
in 1× passive lysis buffer was assayed as a positive con-
trol. Half of the lysed sample material (25 μl) was used
in the assays, and the remaining lysate was frozen at
-20 °C for DNA extraction to be used in the Quantitative
real-time PCR assay. Luciferase activity was measured at
4, 8, 24 and 48 h after electroporation in B. bigemina and
B. bovis promoters, and at 72 h after electroporation for B.
bovis promoter.
Quantitative real-time PCR
A quantitative real-time PCR (qPCR) was standardized
to assess the copy numbers of luciferase (luc) gene, B.
bigemina limulus coagulation factor C domain protein
(ccp)-3 gene and B. bovis merozoites surface protein
(msa)-1 gene in the transfected B. bigemina and B. bovis
parasites. In B. bigemina culture samples were collected
at 8 h post-electroporation, and in B. bovis culture sam-
ples were collected at 24 h post-electroporation. A set of
primers were designed to amplify an: (i) 152 bp fragment
of luc gene: 5′-GGT TTT GGA ATG TTT ACT-3′ and
5′-GCG AAG AAG GAG AAT AG-3′; (ii) 84 bp frag-
ment of B. bigemina ccp-3 gene: 5′-TAC TCG TTC
TAC ACA TTC C-3′, 5′-AAA CCA AGC AAC CTT
AC-3′; and (iii) 150 bp fragment of B. bovis msa-1 gene:
5′-GAT GCG TTT GCA CAT GCT AAG-3′ and 5′-
CGG GTA CTT CGG TGC TCT CA-3′. The qPCR
were performed in a CFX96™ Real-Time PCR Detection
System using the SsoAdvanced™ Universal SYBR® Green
Supermix (Bio-Rad, Richmod, USA) for luc and ccp-3
genes and TaqMan® Universal PCR Master Mix (Life
technologies, Carlsbad, USA) for msa-1 gene. The cyc-
ling conditions consisted of an enzyme activation step of
95 °C for 3 min followed by 40 cycles of 95 °C denatur-
ation for 5 s and annealing/extension of 60 °C for 5 s for
luc and ccp-3 genes and for msa-1 gene the cycling con-
ditions consisted of an enzyme activation step of 95 °C
for 10 min followed by 40 cycles of 95 °C denaturation
for 10 s and annealing/extension of 55.8 °C for 15 s. Re-
actions were performed in triplicate in 20 μl volume
using 500 nM of each primer for luc gene or 200 nM of
each primer for B. bigemina ccp-3 or B. bovis msa-1
genes and 5 μl of pDNA used as standard curve and 2 μl
of pDNA samples. The CFX Manager™ Software (Bio-
Rad) was used to analyze the qPCR data, and the specifi-
city and analytical sensitivity was assessed by melt curve
analyses and standard curve, respectively. Copy numbers
of luciferase, B. bigemina ccp-3 and B. bovis msa-1
genes were calculated based on a standard curve as pre-
viously described [19]. Statistical significance was ana-
lyzed using a two-sample t-test for differences among
the treatment groups.
Results and discussion
Features and full sequence of the ef-1α locus in B.
bigemina
The search for the B. bigemina Bond strain ef-1α locus
identified a single contig (contig 4117.1) containing a
truncated ef-1α orf followed by a 1.4 kb intergenic (IG) re-
gion and a full size ef-1α orf (Fig. 1). These data suggests
that the B. bigemina genome contains an ef-1α locus
which is structurally similar to the locus found in B. bovis
and Plasmodium [12]. A full and identical ef-1α gene copy
A was found to be located in the 5′ region upstream of
the incomplete sequence reported in the Sanger database
in the Puerto Rico B. bigemina strain. Further sequence
analysis of the ef-1α locus of the Puerto Rico B. bigemina
strain showed a putative glutamyl tRNA synthase gene
located immediately upstream to the ef-1α-B gene (Gen-
Bank accession number XM_012911268.1). Synteny
among these two genes is also conserved in the B. bovis
and Plasmodium genomes [12]. Based on this information,
we also obtained the full sequence of the ef-1α gene A and
confirmed the full B. bigemina ef-1α locus structure by
performing PCR amplifications on the Puerto Rico strain
of B. bigemina (Fig. 1).
Full sequencing of the PCR products (Lane 1, Fig. 1)
revealed an ef-1α orf A which is identical to the ef-1α B
gene (Lane 2, Fig. 1), and provided novel sequence data
for the IG region and ef-1α gene B, with a few base dis-
crepancies when compared to data of the unfinished
genome (GenBank accession number KT439182). Over-
all, analysis of the PCR products confirmed that B. bige-
mina contains an ef-1α locus which is identical in
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structure to the B. bovis locus, consisting of two identi-
cal 1.347 kb ef-1α orf ’s which are separated by a
1.425 kb IG region as represented in the top panel of
Fig. 1. Furthermore, BLAST searches performed with the
full size ef-1α locus deduced from the Puerto Rico strain
(GenBank accession number KT439182) shows 99 %
identity with a 4.119 kb region located in the assembled
Chromosome 1 of B. bigemina Bond strain (bp 1849423-
1853541) (GenBank accession number LK391707).
While the sequences of the ef-1α orf ’s from B. bovis
and B. bigemina are highly similar (88 % identity), the
sequence of the B. bigemina IG region is unrelated (no
significant homology detected) to the B. bovis IG region.
Yet, the B. bigemina and the B. bovis ef-1α IG regions
have similar structural features, including the presence
of inverted repeats (IR) (Figs. 1 and 2a). The B. bovis IG
region IR includes the first 260 bp in their 3′ and 5′
ends, whereas, the B. bigemina IG region has slightly
shorter 243 bp IR regions. Oddly, a conserved ClaI site
is located in exactly the same position in the ef-1α IG
regions in both parasites (Figs. 1 and 2a) [12]. No other
repetitive sequence was found in the B. bigemina IG
region beyond the inverted repeat regions (Fig. 2a, b).
Moreover, transcriptional analysis performed by RACE
(Fig. 2) also demonstrated a putative start of transcrip-
tion of the ef-1α and the presence of an intron in the 5’
UTR regions of the B. bigemina (Fig. 2b, c). The se-
quence of the 5’-RACE-derived ef-1α transcript was
deposited in GenBank (Accession number: KT439182).
The presence of an intron in the 5’ UTR of the ef-1α orfs
is another structural feature shared among the B. bovis
and the B. bigemina ef-1α loci. The sequence and struc-
ture of the 5’UTR and the intron are shown in Fig. 2b.
Homologous promoter activity of two distinct IG
fragments demonstrated the presence of two distinct
promoter regions
The promoter activity of two fragments termed Ig-A and
Ig-B, derived from each half of the ef-1α IG region of B.
bigemina was tested using luciferase assays. The
Fig. 2 a Schematic representation of the B. bigemina ef-1α IG region.
The full B. bigemina ef-1α IG region is represented in panel A, the
regions containing the 243 bp IR are represented in blue boxes. The
Ig-A (712 bp) and Ig-B (713 bp) fragments used for promoter analysis
are represented with blue arrows. b Sequence of the 5’ end of the
ef-1α transcript. Alignment of the Ig-A (rev) and Ig-B fragments of the
IG region represented in Panel A. The 5’ end of the sequence of the
RACE product is marked in red, and the intron in blue fonts. c Agarose
gel electrophoresis analysis of the 5’ RACE products obtained from
total B. bigemina RNA. Lane 1, PCR product for 5’- race-1-ef-1α + UPM
primer; Lane 2, PCR product for race-2-ef-1α +UPM primer; Lane 3, PCR
product for race-3-ef-1α + UPM primer. Amplicons are marked with a
red box. Molecular size marker is indicated on the left. Abbreviation: M,
molecular size ladder, 1000 bp DNA ladder
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transient transfection plasmid contained either the frag-
ment Ig-A representing 712 bp upstream of the ef-1α orf
A, or the fragment Ig-B representing 713 bp upstream of
the start of the ef-1α orf B (Fig. 2a). The plasmid vectors
using in the transfections are shown in Fig. 3a and b.
Luciferase expression reached a peak at 8 h after electro-
poration, regardless of the IG region used as promoter
(Fig. 3a). The results comparing expression of luciferase
at 8 h post-electroporation for each construct are shown
in detail in Fig. 3b (F(5,12) = 20.63, P = 0.000). Compara-
tive growth curves and statistical analysis (Fig. 3a and
Additional file 1: Figure S1a) shows that B. bigemina via-
bility at 8 h post-electroporation was equally affected
among all transfected plasmids regardless of the plasmid
used for electroporation (F(6,14) = 0.75, P = 0.617). In
addition qPCR demonstrated similar efficiencies of tran-
sient transfection for all plasmid/parasite combination
used in the study. The qPCR was performed using the B.
bovis 3′ termination msa-1sequence, which is unique to
the transfection plasmid, ccp3, a single gene copy of the
Fig. 3 a Homologous function of the B. bigemina IG promoters. Functional promoter analysis of the B. bigemina IG region in B. bigemina
transfected parasites. The Y axis represents the percentage of parasitized erythrocytes (PPE), and the Z axis represents Relative Luciferase Units
(RLU). The X axis represents the different plasmid constructs (Ig-A, Ig-A Rev, Ig-B, Ig-B Rev, 4-35-ef-luc, Pr-, pBluescript) transfected and the control
(4-35-ef-luc not transfected) at the time of the measurements performed at different hours post-electroporation. The black bars represent the PPE
± standard deviation (SD). The grey line represents relative luciferase units (RLU). b Schematic representation of the plasmid constructs
used in the transient transfections and the RLU obtained eight hours after electroporation. Asterisks represent statistically significant differences
detected using the t- test (P < 0.01)
Fig. 4 Efficiency of transient electroporation of B. bigemina. The number
of plasmid DNA copies per genome was calculated from real time PCR
analysis at eight hours after electroporation. The Y axis represents the
ratio of plasmid/genome copies (Luc/genome copies) and the X axis
represents the different plasmid constructs used in the electroporation.
No significant differences were detected among the different plasmids
electroporated into B. bigemina
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B. bigemina genome and the luc gene [20] (Fig. 4). No
significant differences in the number of plasmids per
genome were found among the distinctly transfected
parasites indicating that the ratios of plasmid gene cop-
ies per genome were identical for all plasmids electropo-
rated in this experiment (Fig. 4) (F(4,10) = 0.73, P = 0.589).
This finding enables a comparison of the relative pro-
moter strengths of the Ig-A and Ig-B regions used in the
study. It can thus be concluded from these data that the
Ig-B fragment, representing sequence upstream of the
ef-1α orf-B in the ef-1α locus, is able to promote the
highest level of luciferase activity when placed in the
5′→ 3′ orientation (F(3,8) = 43.57, P = 0.0001 at 8 h), in-
dicating that this fragment contains a relatively strong
promoter. The Ig-A fragment cloned in the 5′→ 3′ orien-
tation also promoted the expression of significantly higher
luciferase activities compared to the control where the
orientation of the sequence was reversed (F(3,8) = 18.33, P
= 0.001 at 8 h), and thus it also contains a promoter.
Therefore, significant levels of luciferase expression were
consistently obtained from transfected parasites contain-
ing the Ig-A and Ig-B fragments when cloned in the
correct 5′→ 3′ orientation suggesting that the ef-1α IG
region contains two independent promoters. The data in-
dicates that the “Ig-B” region possesses higher promoter
activity than the “Ig-A” region. However, this finding
should not be interpreted as an indication of the ac-
tual strength of the “native” ef-1α-A and ef-1α-B pro-
moters as they are arranged in the locus. True
promoter strength should be estimated using full size
IG regions cloned in the appropriate configuration rela-
tive to the target orf. Even if this is the case, this ex-
perimental approach, based on promoter regions cloned
in transiently transfected plasmids, would not allow esti-
mating the possible regulatory role of distantly located
or “trans” enhancers, as well as the activity of other
regulatory elements such as epigenetic factors. In addition,
it is also possible that the promoter activity can be dis-
tinctly regulated in different stages of the life-cycle of the
parasite, and the data discussed here may be applicable
only to intra erythrocyte parasites developing in in vitro
cultures. Therefore, it is likely that the absolute strength
of these promoters as well as the study of its regulations
could not be properly assessed using a limited transient
Fig. 5 a Heterologous function of the B. bigemina IG promoters. Functional promoter analysis of the B. bigemina IG regions in B. bovis transfected
parasites. The Y axis represents the PPE, and the Z axis represents RLU. The X axis represents the different plasmid constructs (Ig-A, Ig-A Rev, Ig-B,
Ig-B Rev, 4-35-ef-luc, Pr-, pBluescript) transfected and the control (4-35-ef-luc not transfected) at the time of the measurements performed at different
hours post-electroporation. The black bars represent the PPE ± standard deviation (SD). The grey line represents relative luciferase units
(RLU). b Schematic representation of the plasmid constructs used in the transient transfections and the RLU obtained 24 h after electroporation.
Asterisks represent statistically significant differences detected using the t- test (P < 0.05)
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transfection approach such as the one used in this study.
In summary, both regions tested seem to have different
promoter strengths, despite conservation of the inverted
repeats, but sequence divergence upstream these regions
may account for differences in promoter strengths. Des-
pite of these considerations, the data allows for the selec-
tion of Ig-B as a relatively strong promoter to be used in
future stable transfection experiments using in vitro culti-
vated parasites.
Heterologous promoter activities of the B. bigemina and
B. bovis ef-1a promoters
We then tested whether a promoter previously identified
in the ef-1α IG region of B. bovis is also functional in B.
bigemina and conversely, whether the B. bigemina ef-1α
promoters described above are also functional in B.
bovis. Luciferase activities in B. bovis transfected with
plasmid 4–35 [5], containing the B. bovis ef-1α promoter
for the ef-1α B gene (Fig. 5a) peaked at 24 h in all cases
(Fig. 5a). After electroporation of the plasmids contain-
ing the B. bigemina ef-1α A and B promoters respect-
ively into B. bovis parasites and, consistent with the data
shown in Fig. 5a, we measured luciferase activities at its
24 h peak (Fig. 5b) (F(5,12) = 12.03, P = 0.0001). The re-
sults of the comparative luciferase activities are shown
in Fig. 5b. Analysis of growth rates performed at 8 and
24 h post-electroporation showed undistinguishable
growth rates for all B. bovis transfected parasites (F(6,14)
= 0.92, P = 0.510 at 8 h and F(6,14) = 2.07, P = 0.123 at
24 h), suggesting that parasite viability is equally affected
by the procedure regardless of the transfection plasmid
used in the electroporation (Additional file 1; Figure
S1b). In addition, qPCR performed as described above
demonstrates identical efficiencies for transfection re-
gardless of the plasmid used (Fig. 6) (F(4,10) = 1.27, P =
0.345), thus allowing comparisons of luciferase activities
among the distinct promoters and estimating their rela-
tive strength under the conditions tested.
The B. bovis ef-1α promoter in Ig-B is able to promote
expression of the luciferase gene in B. bigemina parasites
at relatively high levels. This can be due to higher trans-
fection efficiencies for the transference of the plasmid
into B. bigemina, to higher affinity of the B. bovis pro-
moter for B. bigemina transcription factors, or alterna-
tively, the lack of proper regulatory signals that can be
involved in the regulation of the activity of the ef-1α
promoter in B. bigemina. However, data in Fig. 6 dem-
onstrates that all plasmids were transferred into the
parasite genome with identical efficiencies, thus preclud-
ing the first possibility. Regardless of the possible expla-
nations for the observed increased efficiency, B. bovis
promoter is functional in B. bigemina parasites. Con-
versely, the B. bigemina promoter is also functional in B.
bovis parasites. Recent work performed in B. bovis
suggested the need for the use of heterologous pro-
moters to increase the efficiency of the targeting of
transfected genes by homologous recombination in this
parasite [21]. Data obtained in this study confirms the
feasibility for the use of heterologous promoters that can
be functional among these two parasites. This will allow
the improvement of B. bovis transfection-based knock-
out (KO) and gene editing technologies, and the devel-
opment of currently unavailable transfection KO systems
for the functional gene characterization in B. bigemina.
Conclusions
In summary, a B. bigemina transient transfection system
able to transfer exogenous DNA into both B. bigemina
and B. bovis parasites was developed. The locus of the B.
bigemina Puerto Rico strain elongation factor-1α was
identified, characterized and the transcriptional activity
of ef-1α promoters tested. This study demonstrates the
existence of two distinct promoters with interchangeable
homologous and heterologous promoter function in B.
bigemina and B. bovis. The observation of interspecies
promoter activity, described for the first time in Babesia
species, is an important step for future stable transfection
construct design and for the production of vaccines based
on transfected parasites for B. bigemina and B. bovis.
Additional file
Additional file 1: Figure S1. a In vitro growth curve of B. bigemina
parasites. The Y axis represents the PPE and X axis represents the
different times points of measurement in hours. The transfected plasmid
constructs are represented in lines Ig-A (blue diamond), Ig-A Rev (red
square), Ig-B (green triangle), Ig-B Rev (purple x), 4-35-ef-luc (light blue
asterisk), Pr- (orange circle) pBluescript (dark blue bar). b In vitro growth
curve of B. bovis parasites. The Y axis represents the PPE and X axis represents
the different times points of measurement in hours. The transfected construct
plasmid are represented in lines Ig-A (blue diamond), Ig-A Rev (red square),
Fig. 6 Efficiency of transient electroporation of B. bovis parasites. The
number of plasmid DNA copies per genome was calculated from
real time PCR analysis at twenty-four hours after electroporation. The
Y axis represents the ratio of plasmid/genome copies (Luc/genome
copies) and the X axis represents the different plasmid constructs
used in the electroporation. No significant differences were detected
among the different plasmids electroporated into B. bigemina
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Ig-B (green triangle), Ig-B Rev (purple x), 4-35-ef-luc (light blue asterisk),
Pr- (orange circle), pBluescript (pBS) (dark blue bar). Black bars represent
standard deviation. ANOVA was used as statistical method of analysis.
The assay was performed in triplicate. (TIF 517 kb)
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